引導式測驗 · 中等 等級

AI 藥物再利用測驗

測試重新利用假設、計算與臨床證據、驗證、暴露和特定適應症的安全性。

相關引導路徑AI 藥物重定位
問題 1 的 8

What does an AI drug-repurposing match establish?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. What does an AI drug-repurposing match establish?
    • A candidate relationship for experimental evaluation
    • That the medicine treats the new disease
    • That its old safety record covers every use
    • That a clinical trial is unnecessary
  2. Why does prior approval not prove safety for a new indication?
    • Approval automatically transfers to every disease
    • The model score sets the safe dose
    • An old indication guarantees new efficacy
    • Dose, population, duration, interactions, and formulation may differ
  3. What should follow a predicted target interaction?
    • A claim of clinical effectiveness
    • An assumption that exposure is achievable
    • Biochemical or cellular experiments that test the proposed mechanism
    • Patient treatment without review
  4. Which clinical-study details are needed to assess a new use?
    • The color of the trial report
    • Population, comparator, endpoint, and treatment timing
    • Only the compound’s brand name
    • Only a model score
  5. Why avoid leakage from known drug-target databases?
    • The model may appear to predict relationships already present in its inputs
    • It makes experimental assays unnecessary
    • It proves the compound is ineffective
    • It changes the medicine’s formulation
  6. What does a target-centric computational pipeline do?
    • Eliminates pharmacokinetic testing
    • Ranks compounds that may interact with a selected biological target
    • Confirms a drug has clinical benefit
    • Determines treatment for individual patients
  7. What must be assessed at a potentially safe, relevant exposure?
    • Whether the patient has internet access
    • Whether the model is reproducible alone
    • Whether the compound produces the proposed effect at that exposure
    • Whether its structure resembles any drug
  8. Should a patient change medication based on an AI repurposing score?
    • Yes, if several models agree
    • Yes, if the compound is already approved
    • Only if the score is above the training mean
    • No; a new use needs evidence and qualified medical guidance